CURE’s myeloma page is a go-to resource for oncology news and updates in the world of myeloma Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in myeloma.
Cristina Gasparetto, MD, gives a brief overview of the multiple myeloma disease state and introduces us to Donna, one of her patients diagnosed with multiple myeloma.
Elie Fahed, MD, provides an overview of what multiple myeloma is, and Beth walks us through her frustrating journey to initial diagnosis as an atypical patient.
June 4th 2023
Elranatamab led to early and deep responses in patients with relapsed/refractory myeloma who were previously treated with a BCMA-directed therapy.
May 18th 2023
Cryopreserved stem cells led to a higher rate of relapse in patients with blood cancer, though there was no difference in survival, research showed.
May 3rd 2023
Mixed in the boxes of appointments and cancer treatments are milestones that uplift my spirits and are unique to my healing journey.
April 29th 2023
Watch Dr. Brandon J Blue, Dr. Surbhi Sidana, Dr. Kenneth H. Shain and Mary Derome answer questions about the future of treatment during the CURE Educated Patient Multiple Myeloma Summit.
April 28th 2023
Watch Dr. Kenneth H. Shain, from Moffitt Cancer Center, discuss the future of myeloma treatment, including BiTE therapy, during the CURE Educated Patient Multiple Myeloma Summit.
April 27th 2023
Patients with myeloma who are being treated with Tecvayli must discuss symptoms of cytokine release syndrome with their providers as soon as they happen.
Watch Dr. Surbhi Sidana, from Stanford Medicine, discuss CAR-T cell therapy during the CURE Educated Patient Multiple Myeloma Summit.
April 26th 2023
Watch Dr. Brandon J Blue, Dr. Dickran Kazandjian and Dr. Marc J. Braunstein answer questions about disease management during the CURE Educated Patient Multiple Myeloma Summit.
April 25th 2023
Watch Dr. Marc Braunstein, from NYU Langone Hospital, discuss the role of bone marrow transplant during the CURE Educated Patient Multiple Myeloma Summit.
April 24th 2023
Watch Dr. Dickran Kazandjian, from Miami Health System, discuss updates in newly diagnosed disease during the CURE Educated Patient Multiple Myeloma Summit.
April 23rd 2023
Watch Dr. Ariel Grajales-Cruz and Dr. Brandon J Blue answer questions about myeloma during the CURE Educated Patient Multiple Myeloma Summit.
April 22nd 2023
Watch Dr. Brandon Blue, from Moffitt Cancer Center, discuss health disparities during the CURE Educated Patient Multiple Myeloma Summit.
April 21st 2023
Watch Dr. Ariel F. Grajales-Cruz, from Moffitt Cancer Center, discuss updates in MGUS and smoldering disease during the CURE Educated Patient Multiple Myeloma Summit.
April 19th 2023
The FDA has accepted a supplemental Biologics License Application for moving up the use of Abecma, a CAR-T cell therapy, for adult patients with multiple myeloma.
April 17th 2023
Omisirge is an umbilical cord blood-based therapy that may prevent infection in patients with blood cancer undergoing stem cell transplant.
April 14th 2023
The Food and Drug Administration granted OM-301 an Orphan Drug Designation for the treatment of patients with myeloma.
April 11th 2023
After the COVID-19 pandemic broadened usage of telehealth, patients with myeloma now have more access to experts in their disease.
March 22nd 2023
A multiple myeloma survivor discusses how continued minimal residual disease negativity made her feel more confident in coming off of maintenance therapy.
March 20th 2023
I’m more than six years out from my myeloma diagnosis and realized that I’m capable of more than just surviving.
March 17th 2023
Triplet therapy demonstrates improved remission and survival rates, with manageable side effects for patients who are ineligible for transplant.
March 3rd 2023
Multiple Myeloma Awareness Month is a time to raise awareness both locally and nationally about efforts to fight myeloma.
February 23rd 2023
Patients who used opioids long-term after undergoing an autologous stem cell transplant tended to have poorer survival outcomes, recent research showed.
February 16th 2023
Carvykti and other drugs prove that there are still options for patients whose myeloma got worse on prior therapies.
February 6th 2023
The Food and Drug Administration granted an investigational new drug application and green lit the continued study of GC012F for the treatment of patients with relapsed/refractory myeloma.
February 5th 2023
As a part of its Speaking Out Video series, CURE® spoke with Kenny Capps, from Throwing Bones for a Cure, about the importance of staying active during a multiple myeloma diagnosis.
As a part of its Speaking Out Video series, CURE® spoke with Kenny Capps, from Throwing Bones for a Cure, about the impact multiple myeloma has on a patient’s mental health and what they can do to help themselves.
As a part of its Speaking Out Video series, CURE® spoke with Dr. Saad Usmani, on behalf of Throwing Bones for a Cure, about the future of multiple myeloma treatments.
January 15th 2023
January 14th 2023
Tumor Treating Fields With Standard of Care May Significantly Improve Survival in Metastatic NSCLC
Adding Opdivo to Chemo May Prolong Survival in Advanced Hodgkin Lymphoma
Enhertu Is Promising for Difficult-to-Treat Solid Cancers
Did I Cause My Cancer Diagnosis?